World News: 19:00 GMT Wednesday 11th July 2018. [Captozyme, Inc. via Businesswire via SPi World News]
Captozyme Inc announced today that it is initiating a prospective double-blind randomized placebo controlled cross-over study with Nephure an oxalate reducing enzyme to determine the extent to which Nephure vs placeb...
Business Wire: 19:00 GMT Wednesday 11th July 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.